Type 1 diabetes trials in South Africa

1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

  Where

  Bloemfontein, Cape Town, Durban, Johannesburg, Lenasia, Mossel Bay, Paarl, Cape Town, Port Elizabeth, Pretoria, Somerset West

  Age

  18 years and over

  People

  2,500 worldwide

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT07564414 · EU 2025-522488-14-00